CVS shareholders approve 2026 incentive plan, re-elect directors at annual meeting

CVS HEALTH Corp

13 directors elected; all management proposals passed including 2026 ICP approval.
2026 Incentive Compensation Plan replaces expiring 2017 plan; effective for awards after May 14, 2026.
Advisory say-on-pay passed with ~94% of votes cast (excluding broker non-votes).
Ernst & Young ratified as independent auditor for 2026 with 1.12B votes for.
Stockholder proposal to reduce written consent threshold failed with ~40% support.

item 5.02item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.